SCHEMBL28025288

SCHEMBL28025288

COCCc1c[nH]nc1-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.35
MAPK1 P28482 1/20 0.35
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 3/20 0.35
RAB9A P51151 2/20 0.35
MAPT P10636 2/20 0.35
GFER P55789 1/20 0.35
NPC1 O15118 1/20 0.35
GAA P10253 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
TTK P33981 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11624564 0.83 ALOX15 (0.41) ALOX15SMN1; SMN2TP53ALDH1A1KDM4E
SCHEMBL14036889 0.83 KDM4E (0.44) ALOX15SMN1; SMN2POLBMAPK1ALDH1A1
SCHEMBL27518476 0.80 ALOX15 (0.35) ALOX15SMN1; SMN2TP53POLBALDH1A1
SCHEMBL20449061 0.79 TAAR1 (0.41) ALOX15SMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL11123121 0.79 ALOX15 (0.43) ALOX15SMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL28024865 0.79 ALOX15 (0.37) ALOX15SMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL5584092 0.79 GPR84 (0.49) ALOX15MAPK1ALDH1A1MAPT
SCHEMBL14094653 0.76 RIPK1 (0.42) ALOX15SMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL28861332 0.75 ALOX15 (0.43) ALOX15SMN1; SMN2TP53ALDH1A1KDM4E
SCHEMBL28583866 0.75 ALOX15 (0.43) ALOX15SMN1; SMN2ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102292321-B Pyrazolyl-substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor for the treatment of receptor-related disorders ARENA PHARMACEUTICALS, INC. (US) 2015-08-12 CN disclosed